Cox Bryan F. 4
4 · TriSalus Life Sciences, Inc. · Filed Dec 19, 2024
Insider Transaction Report
Form 4
Cox Bryan F.
CHIEF OF RESEARCH
Transactions
- Sale
Common Stock
2024-10-05$4.44/sh−314$1,394→ 86,382 total
Footnotes (1)
- [F1]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on May 19, 2023 for 4,127 shares.